Quantbot Technologies’s Xeris Biopharma Holdings XERS Stock Holding History

Quantbot Technologies’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$163K	Sell	28,064 -49,584	-64%	-$329K	0.01%	1222
2025 Q4	$610K	Buy	77,648 +8,283	+12%	+$65.2K	0.02%	857
2025 Q3	$565K	Buy	69,365 +26,420	+62%	+$176K	0.02%	976
2025 Q2	$201K	Sell	42,945 -11,162	-21%	-$51.1K	0.01%	1236
2025 Q1	$297K	Buy	+54,107	New	+$218K	0.01%	1038
2024 Q4	–	Sell	-15,425	Closed	-$44K	–	1883
2024 Q3	$44K	Buy	+15,425	New	+$39.6K	﹤0.01%	1303
2021 Q1	–	Sell	-935	Closed	-$4K	–	1808
2020 Q4	$4K	Buy	935 +135	+17%	+$675	﹤0.01%	1185
2020 Q3	$4K	Buy	+800	New	+$3.2K	﹤0.01%	1204

Other funds holding XERS

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $244M AUM 80.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return